高清一级毛片一本到免费观看_午夜精品久久久久久久99热_国产乱理伦片在线视频观看_国产精品视频永久免费播放_亚洲国产精品成人久久

Our Science

Science & Innovation

Pipeline

Dorzagliatin

mGluR5

Poster and Presentation

Peer Reviewed Publications

Product

HuaTangNing(華堂寧®)

Investor Relations

Investor Center

Corporate Governance

Financial Report

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Media

Company News

Media Releases

Video

About Us

Company Overview

Company History

Leadership Team

Partner

Portfolio Advisory Board

Senior Scientific Advisory Board

Media Center

Careers

Company Culture

Join Us

Contact Us

中

繁

中

繁

中

• Our Science

  Science & Innovation

  Pipeline

  Dorzagliatin

  mGluR5

  Poster and Presentation

  Peer Reviewed Publications

• Product

  HuaTangNing(華堂寧®)

• Investor Relations

  Investor Center

  Corporate Governance

  Financial Report

  Announcements and Circulars

  Listing Documents

  Investor Presentation

  IR Contact

  Investor Calendar

  Stock Information (2552.HK)

  Corporate Communications

• Media

  Company News

  Media Releases

  Video

• About Us

  Company Overview

  Company History

  Leadership Team

  Partner

  Portfolio Advisory Board

  Senior Scientific Advisory Board

  Media Center

• Careers

  Company Culture

  Join Us

• Contact Us

Investor Relations

 >  Investor Relations

 >  Announcements and Circulars

Investor Center

Corporate Governance

Financial Report

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Announcements and Circulars

Search

Mar 31, 2023

Resignation of independent non-executive director and change in composition of the board committees

Read More

Mar 29, 2023

Annual results announcement for the year ended december 31, 2022

Read More

Mar 17, 2023

Date of board meeting

Read More

Mar 06, 2023

Monthly Return

Read More

Feb 16, 2023

Voluntary Announcement - Clarification and Unaudited Business Update in Relation to Media Coverage Relating to Commercialization Progress of Huatangning

Read More

Feb 08, 2023

Voluntary Announcement - Business Update on Receipt of Milestone Payments Under The Commercialization Agreement in Relation to Huatangning

Read More

Feb 06, 2023

Monthly Return

Read More

Jan 06, 2023

Monthly Return

Read More

Dec 30, 2022

Appointment of independent non-executive director and change in composition of audit committee and remuneration committee

Read More

Dec 06, 2022

Monthly Return

Read More

Dec 01, 2022

Grant of share options

Read More

Nov 24, 2022

Passing away of an independent non-executive director

Read More

• <<
• <
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• >
• >>

上一頁(yè)

下一頁(yè)

About Us

Company Overview

Company History

Leadership Team

Portfolio Advisory Board

Senior Scientific Advisory Board

Partner

Media center

Research & Development

Inovation

Pipeline

Dorzagliatin

mGluR5

Company Publications

Peer Reviewed Publications

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Media

Company News

Media Releases

Video

Careers

Culture

Join Us

Product

HuaTangNing(華堂寧®)

Subscribe Email

Focus Us

Copyright © 2025  Hua Medicine (Shanghai) Co., Ltd.    網(wǎng)際網(wǎng)路藥品信息服務(wù)資格證書(shū)編號(hào): （滬）-非經(jīng)營(yíng)-2022-0079
滬ICP備14036654號(hào)-1   滬公網(wǎng)安備 31011502013809號(hào)  Privacy Statement  Terms of Use

Search

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.

Accept

x